Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ACCENTIA BIOPHARMACEUTICALS INC (ABPI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-12Sep-30-11Sep-30-10Sep-30-09Sep-30-08Sep-30-07Sep-30-06Sep-30-05
   10-K10-K10-K10-K10-K10-K10-K10-K
Net Sales:          
Products  3.02.44.2     
Services  0.81.31.2     
Grant revenue  0.20.3      
    Total net sales  4.14.05.410.615.918.325.125.2
            Total net sales growth  2.5%-26.1%-49.3%-26.0%-12.9%-27.0%-0.5%-2.9%
Cost of sales:          
Products  1.91.52.0     
Services  0.91.00.9     
Grants   0.1      
    Total cost of sales (exclusive of amortization of acquired product rights)  2.82.52.9     
    Gross margin  1.31.52.5     
            Gross margin  31.7%37.1%45.8%     
   
Operating expenses:          
Research and development  5.22.21.3     
Royalty  0.00.0      
Sales and marketing  0.10.10.1     
General and administrative  7.420.24.2     
    Total operating expenses  29.422.66.1     
    Operating loss  -11.5-21.2-3.6     
            Operating margin  -284.6%-535.2%-67.3%     
   
Other income (expense):          
Interest expense  -7.9-8.1-16.7     
Derivative gain  1.41.1-28.8     
Other (expense) income  0.00.00.6     
    Loss before reorganization items, non-controlling from variable interest entities, discontinued operations and income taxes  -18.0-28.2      
   
Reorganization items:          
Professional fees  -0.1-0.4-1.1     
Gain on reorganization  5.712.70.1     
    Total reorganization items  5.612.4-1.1     
    Loss before discontinued operations, income taxes, and non-controlling interest  -12.4-15.8-47.4-5.3-60.8-76.0-43.4-44.7
   
Discontinued operations:          
Income from discontinued operations, including gain from sale of assets  3.80.2      
Income tax expense  -0.6       
    Income from discontinued operations  3.20.2-0.8     
    Loss before income taxes and non-controlling interest  -9.2-15.6-48.2     
Income taxes   0.00.0     
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%  
    Net loss  -9.2-15.7-48.2     
Loss from non-controlling interest from variable interest entities and subsidiary  4.94.10.4     
    Loss attributable to common shareholders  -4.3-11.6-50.1-5.30.00.00.00.0
   
Weighted average shares outstanding, basic and diluted  80.768.458.0     
   
Per share amounts, basic and diluted          
Loss from continuing operations  0.00.00.0     
Loss from discontinuing operations  0.0       
   
Loss attributable to common stockholder  ($0.05)($0.17)($0.86)     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy